Parenteral formulations comprising carbamazepine or its derivatives
AssigneeNovartis AG
InventorPeter Van Hoogevest
Life of this patent
Estimating the term…
Abstract
This invention is concerned with a parenteral formulation comprising a 5H-dibenz(b,f)azepine-5-carboxamide and an aqueous-based solvent. The parenteral formulation is useful in the treatment of seizures resulting from, e.g. epileptic attack.
Claims10
A parenteral formulation comprising a 5H-dibenz(b,f)azepine-5-carboxamide and water or an aqueous-based solvent wherein the formulation contains no other solubilising aids.
A parenteral formulation comprising a 5H-dibenz(b,f)azepine-5-carboxamide, water or an aqueous-based solvent and glucose.
A parenteral formulation comprising 10-hydroxy-10,11-tetrahydrocarbamazepine and water.
A unit dosage form comprising an effective amount of a 5H-dibenz(b,f)azepine-5-carboxamide and water or an aqueous-based solvent wherein the unit dosage form contains no other solubilising aids.
A container having a fill volume of from about 100 to about 250 ml and containing in solution a therapeutically effective amount of a 5H-dibenz(b,f)azepine-5-carboxamide.
Method of treating epilepsy in a subject which comprises administering a parenteral formulation as claimed in any of the preceeding claims.
Use of a parenteral formulation as defined in any of the preceding claims in the treatment of epilepsy.
Dependencies are inferred from the claim text.